Hi, can anyone suggest one good method to identify variations from one NGS sample? I have read some methods in published papers, it seems that lots of them consider the observed priori probability of mutation is the same with SNP, 0.001. However, I think the ratio of heterotype SNVs should be larger than that, probably near 0.5. (Maybe I am confused, 0.001 is very useful for novel mutations finding) Meanwhile, is there any good programs for somatic mutations discovering, when two samples are used (control+)? I have tried to identify them by the following procedure: a.Identify mutations in different samples respectively.b. Find the difference between them and name them somatic mutations. However, this could generate a big number of somatic mutations. I think it would be more reasonable if the number is a bit smaller. Besides, this procedure does not consider mutations that occur in both of the two samples, but vary in allele frequency. Very appreciated if you could give me some suggestions.
-
Last edited by dingxiaofan1; 01-03-2011, 08:14 PM. -
I do not know if it can help to you, but it seems that the optimal pipeline for finding somatic mutations in tumor/normal samples with GATK is the following:
http://www.broadinstitute.org/gsa/wi..._recalibration
That is, to work with a single bam file for each tumor/normal pair throughout the workflow steps once their reads are mapped.
Actually, I'm also working on it, since once the normal/tumor mutations are detailed in the final single vcf file, I do not know which is the most approppriate way of declaring them as either somatic or germline. -
@dingxaiofan1
Can you explain exactly what you mean when you say "variations from one NGS sample"? Do you mean between that sample and a reference sequence or the between the two haplotypes in that single individual, which would be the number of heterozygous SNVs? I think the .001 probability is what you want to use in either case. What variant calling procedure are you using?
I think the procedure you describe is the most common way of looking for somatic mutations- call variants in both control and non-control samples and find the differences. Depending on your data and your variant calling method it should be possible to detect SNVs mutations that occur in both samples,but are heterozygous in one and homozygous in the other.
Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM
Comment